Ra Capital Management, L.P. - Oct 17, 2022 Form 4 Insider Report for DICE Therapeutics, Inc. (DICE)

Role: Director, 10%+ Owner
Signature: /s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Stock symbol: DICE
Transactions as of: Oct 17, 2022
Transactions value $: $59,860,000
Form type: 4
Date filed: 10/19/2022, 04:32 PM
Previous filing: Oct 14, 2022
Next filing: Oct 20, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DICE	Common Stock	Purchase	$59.9M	+1.64M	+31.48%	$36.50	6.85M	Oct 17, 2022	See Footenotes	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	6,062,504 shares are held directly by the RA Capital Healthcare Fund, L.P (the "Fund") and 786,407 sahres are held directly by RA Capital Nexus Fund II, L.P. (the "Nexus Fund II").
F2	RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund II. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Content

6,062,504 shares are held directly by the RA Capital Healthcare Fund, L.P (the "Fund") and 786,407 sahres are held directly by RA Capital Nexus Fund II, L.P. (the "Nexus Fund II").

RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and the Nexus Fund II. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.